Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Autoimmunity Reviews
|
March 22, 2014
14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome
Guilherme R de Jesus, Nancy Agmon-Levin, Carlos A Andrade, et al.
Arthritis and Rheumatism
|
January 26, 2012
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies
Michael D Lockshin, Mimi Kim, Carl A Laskin, et al.
Prenatal Diagnosis
|
November 18, 2009
Influence of maternal BMI on genetic sonography in the FaSTER trial
Kjersti M Aagaard-Tillery, T Flint Porter, Fergal D Malone, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 2008
First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study
Geralyn Lambert-Messerlian, Monica McClain, James E Haddow, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 12, 2008
Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy
James E Haddow, Monica R McClain, Geralyn Lambert-Messerlian, et al.
American Journal of Obstetrics and Gynecology
|
May 2, 2008
Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study
Monica R McClain, Geralyn Lambert-Messerlian, James E Haddow, et al.
Obstetrics and Gynecology
|
January 22, 2011
Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption
James E Haddow, Monica R McClain, Glenn E Palomaki, et al.
Lupus Science & Medicine
|
February 3, 2016
Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results
Cecile M Yelnik, Carl A Laskin, T Flint Porter, et al.
Obstetrics and Gynecology
|
June 23, 2010
Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery
James E Haddow, Jane Cleary-Goldman, Monica R McClain, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 19, 2016
Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes
Cecile M Yelnik, T Flint Porter, D Ware Branch, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Autoimmunity Reviews
|
March 22, 2014
14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome
Guilherme R de Jesus, Nancy Agmon-Levin, Carlos A Andrade, et al.
Arthritis and Rheumatism
|
January 26, 2012
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies
Michael D Lockshin, Mimi Kim, Carl A Laskin, et al.
Prenatal Diagnosis
|
November 18, 2009
Influence of maternal BMI on genetic sonography in the FaSTER trial
Kjersti M Aagaard-Tillery, T Flint Porter, Fergal D Malone, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 2008
First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study
Geralyn Lambert-Messerlian, Monica McClain, James E Haddow, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 12, 2008
Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy
James E Haddow, Monica R McClain, Geralyn Lambert-Messerlian, et al.
American Journal of Obstetrics and Gynecology
|
May 2, 2008
Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study
Monica R McClain, Geralyn Lambert-Messerlian, James E Haddow, et al.
Obstetrics and Gynecology
|
January 22, 2011
Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption
James E Haddow, Monica R McClain, Glenn E Palomaki, et al.
Lupus Science & Medicine
|
February 3, 2016
Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results
Cecile M Yelnik, Carl A Laskin, T Flint Porter, et al.
Obstetrics and Gynecology
|
June 23, 2010
Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery
James E Haddow, Jane Cleary-Goldman, Monica R McClain, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 19, 2016
Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes
Cecile M Yelnik, T Flint Porter, D Ware Branch, et al.
Page
of 6